Public Reporting A4086

As required by CMS, the information on this webpage contains our Public Reporting information

ACO Name and Location:

DVACO-3,LLC
Previous Names: N/A
259 North Radnor Chester Road
Suite 290
Radnor, Pennsylvania 19087

ACO Primary Contact

Primary Contact Name Jeanette Flood
Primary Contact Phone Number 610-225-6210
Primary Contact Email Address floodj@dvaco.org

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Annesley Flangan Fischer Stefanyszyn And Associates N
Associates in Plastic Surgery, Inc N
Balmont Family Practice N
Brian Abaluck, LLC (Main Line Center for Sleep and Memory) N
Broker, Cramer & Swanson ENT, PC (ENT and Allergy Specialists) N
David E Samuel DPM (Foot & Ankle Specialists of Delaware County) N
Deebeanne M. Tavani, DO, Ph.D N
Delaware Valley Community Health, Inc. N
Delaware Valley I.D. Associates, P.C. N
Endeavor Health LLC N
Great Valley Neurological Associates LLC N
Healthmark Foot and Ankle Associates, P.C. N
Jefferson Acute Care Physicians, PC (Jefferson Urgent Care) N
Jefferson University Physicians N
Lawrence I. Katin, MD, PC N
Lisa Linder N
Lower Merion Rehabilitation N
Magee Rehabilitation Hospital N
Main Line Allergy, L.L.P. N
Main Line Emergency Medicine Associates LLC N
Main Line Health HomeCare and Hospice N
Main Line Health Imaging, LP N
Main Line Hospitals, Inc. (Bryn Mawr Hospital, Bryn Mawr Rehabilitation Hospital, Lankenau Medical Center, Mirmont Treatment Center, Paoli Hospital, Riddle Hospital) Y
Main Line Institute of Plastic Surgery Inc N
Main Line Pathology Associates, PC N
Main Line Radiation Oncology PC N
Marc D Baer DPM LLC (Foot and Ankle Center) N
Marple Medical Associates N
Mazzoni Center N
Medical Associates of the Main Line, PC N
Michael R. Grossman, DPM (Main Line Foot and Ankle Center) N
Minh Thieu, MD, PC (Innovative Dermatology) N
Morgenstern Center for Orbital and Facial Plastic Surgery, Inc. N
Pace Foot and Ankle Centers, PLLC N
Philadelphia Health Associates – Adult Medicine, P.C. N
Podiatry Care Specialists P C N
Project HOME N
Providence Ear Nose & Throat Associates Inc. N
Pulmonology Associates Inc. N
Radiology Associates of the Main Line, PC N
Rehabilitation Associates of the Main Line, P.C. N
Rheumatology Medical Specialists PC N
Roy M Lerman MD PC (Main Line Spine) N
Segal Aaronson Pulmonary Associates N
Suburban Endocrinology Associates, PC N
Sutera & Jones Surgical Podiatry PC N
Thomas Jefferson University Hospitals, Inc. (Jefferson Hospital for Neuroscience, Methodist Hospital, Thomas Jefferson University Hospital) Y
United Anesthesia Services, PC N
William J. Lewis, M.D., P.C. (Main Line Ear, Nose and Throat/Head and Neck Surgery) N
Your Next Step PC N

ACO governing body:

Member Member’s Voting Power– Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Mankin, M.D. Eric   1 ACO Participant Representative Main Line Hospitals, Inc.
Pribitkin, M.D. Edmund Co-Chair 1 ACO Participant Representative Jefferson University Physicians
Angelo, M.D. Mark   1 Other: ACO Acting President & Chief Executive Officer N/A
Harrop, M.D. Catriona   1 ACO Participant Representative Thomas Jefferson University Hospitals, Inc.
Livornese, M.D. Lawrence   1 ACO Participant Representative Delaware Valley Infectious Disease Associates
Rubin, M.D. Seth   1 ACO Participant Representative Main Line Hospitals, Inc.
Smullens, M.D. Stanton   1 Medicare Beneficiary Representative N/A
Ward, M.D. Lawrence   1 ACO Participant Representative Thomas Jefferson University Hospitals, Inc.

Key ACO clinical and administrative leadership:

Mark Angelo, M.D., MHA, FACP ACO Executive (Acting President & CEO)
Mark Angelo, M.D., MHA, FACP Medical Director (Chief Clinical Officer)
Christopher Jackson Compliance Officer
Virginia Bodycot, BSN, RN Quality Assurance/Improvement Officer (Director, Quality Improvement)

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Audit and Finance Committee Michael J. Buongiorno (Chair)
Clinical Integration Committee Katherine Behan, M.D. (Co-Chair)
Eric Mankin, MD (Co-Chair)

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Federally Qualified Health Center (FQHC)
  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2020, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1* CAHPS: Getting Timely Care, Appointments, and Information N/A N/A
ACO-2* CAHPS: How Well Your Providers Communicate N/A N/A
ACO-3* CAHPS: Patients’ Rating of Provider N/A N/A
ACO-4* CAHPS: Access to Specialists N/A N/A
ACO-5* CAHPS: Health Promotion and Education N/A N/A
ACO-6* CAHPS: Shared Decision Making N/A N/A
ACO-7* CAHPS: Health Status/Functional Status N/A N/A
ACO-34* CAHPS: Stewardship of Patient Resources N/A N/A
ACO-45* CAHPS: Courteous and Helpful Office Staff N/A N/A
ACO-46* CAHPS: Care Coordination N/A N/A
ACO-8[1] Risk Standardized, All Condition Readmission 15.64 15.07
ACO-38[1,2] All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 53.91 49.50
ACO-43[3] Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 0.67 0.95
ACO-13 Falls: Screening for Future Fall Risk 93.70 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 86.30 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 90.48 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 74.09 71.46
ACO-19 Colorectal Cancer Screening 72.40 72.59
ACO-20 Breast Cancer Screening 76.98 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 85.36 83.37
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9%) 23.60 14.70
ACO-28 Controlling High Blood Pressure 63.20 72.87

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

*CAPHS reporting suspended for 2020 Performance Year.

[1] Due to the COVID-19 Pandemic, ACO-8 and ACO-38 have reverted to pay-for-reporting measures for Performance Year 2020 and are not eligible for QI Reward points, although prior rates are shown for informational purposes.
[2] CMS recently updated the calculation risk adjustment methodology for ACO-38 to correct a non-material technical error. These rates were previously updated in the 2020 Q4 Quarterly Quality Report.
[3] ACO-43 was converted to pay-for-reporting for Performance Year 2020 due to a substantive change and is not eligible for QI Reward points, although prior rates are shown for informational purposes.

Contact Information

Address PO Box 356, Villanova, PA 19085
Phone 610-225-6295
Toll Free Number 855-761-9345
TTY# 610-225-6275
Compliance Line 610-225-6211
Email dvacomail@dvaco.org
Business Hours 9-5pm